trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['tdxd', 'ascertain']
#asco23 the probability of finding her2low on mets progressively increases with increasing number of biopsies. it may have come the time to consider tdxd administration based on the assumption of her2low presence rather than the actual ascertainment of it 
Ricercatore Oncologia Medica - Oncology Fellow, University of Padova